Vital Care Infusion Services, LLC Appoints Brett Dethmers As Chief Financial Officer

“I am thrilled to be a part of the Vital Care team and work with such wonderful professionals who are passionate about supporting the infusion services industry and taking care of patients,” said Brett Dethmers. “Vital Care has experienced significant growth over the last few years as the overall industry continues to expand and demand for infusion therapy increases, so it’s a very exciting time to join the brand. I look forward to being a valued asset to the corporate team and Vital Care’s franchise owners during this momentous period in the company’s history.”

Brett Dethmers completed his undergraduate degree in business administration at the University of Wisconsin-Oshkosh and earned an MBA from the University of Chicago’s Booth School of Business. His previous experience includes financial management roles at healthcare companies including ModernHealth, Kroger Specialty Pharmacy, Kroger Prescription Plan, and SMP Pharmacy Solutions.

“We see Brett as a vital piece of our strategic partnership with Linden Capital Partners, and we look forward to his ability to bring his financial management expertise and his healthcare management mindset to the Vital Care system. He will actively provide crucial support to our existing and new franchisees for even greater success,” said Ed Eiland, CEO of Vital Care. “We are encouraged about what he is doing already to continue supporting our mission and vision.”

Founded in 1986, Vital Care brand’s mission is to partner with pharmacy owners across America to provide patients with professional, compassionate, safe, and cost-effective infusion services. Its vision is to be the infusion provider for the communities it serves, improving the lives of patients and health care professionals through access to the best service possible.

Vital Care franchised pharmacies provide infusion services such as anti-infectives, parenteral and enteral nutrition, inotropic agents, immunoglobulin, and many biologics and biosimilars, in addition to other key therapies that are able to be safely administered in the home setting and alternate sites of care. All locations comply with federal and state standards for preparation of sterile products and are also accredited by the Accreditation Commission for Health Care (ACHC).